{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T18:38:13Z","timestamp":1778265493717,"version":"3.51.4"},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T00:00:00Z","timestamp":1068768000000},"content-version":"vor","delay-in-days":2357,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Several studies have shown that dual therapy with omeprazole and amoxycillin may cure <jats:italic>Helicobacter pylori<\/jats:italic> infection. However, the optimum dose of omeprazole has still to be established.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>An international, randomized, double\u2010blind multicentre trial was conducted in patients with duodenal ulcers to compare the <jats:italic>H. pylori<\/jats:italic> cure rates obtained by dual therapy consisting of either omeprazole 20\u2003mg b.d. plus amoxycillin 750\u2003mg b.d. or omeprazole 40\u2003mg b.d. plus amoxycillin 750\u2003mg b.d. for 2 weeks. Dual therapy was followed by omeprazole 20\u2003mg once daily for 2 weeks. Before entering the trial and 4 weeks after cessation of treatment <jats:italic>H. pylori<\/jats:italic> infection was assessed by histology and a <jats:sup>13<\/jats:sup>C\u2010urea breath test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>381 patients were randomized into the study, of whom 345 were evaluable for the all\u2010patients\u2010treated analysis of efficacy and 378 were valid for the evaluation of safety. Histology results showed that <jats:italic>H. pylori<\/jats:italic> infection was cured in 64 out of 174 patients treated with omeprazole 20\u2003mg b.d. plus amoxycillin and in 102 out of 171 patients treated with omeprazole 40\u2003mg b.d. plus amoxycillin (37% vs. 60%; <jats:italic>P<\/jats:italic>\u2003&lt; \u20030.001). Both treatment regimens were well tolerated, with adverse events reported by 29 (15.2%) and 35 patients (18.7%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>This study has shown that dual therapy with amoxycillin 750\u2003mg b.d. and omeprazole 40\u2003mg b.d. is superior to dual therapy with amoxycillin and omeprazole 20\u2003mg b.d. in patients with <jats:italic>H. pylori<\/jats:italic>\u2010positive duodenal ulcers. Thus, a true dose\u2013response relationship exists between omeprazole and treatment success. However, a combination of omeprazole with two of amoxycillin, clarithromycin and a nitroimidazole is a preferable alternative for routine clinical use.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1997.00169.x","type":"journal-article","created":{"date-parts":[[2003,11,14]],"date-time":"2003-11-14T11:46:44Z","timestamp":1068810404000},"page":"515-522","source":"Crossref","is-referenced-by-count":19,"title":["Doubling the omeprazole dose (40\u2003mg b.d. vs. 20\u2003mg b.d.) in dual therapy with amoxycillin increases the cure rate of <i>Helicobacter pylori<\/i> infection in duodenal ulcer patients"],"prefix":"10.1111","volume":"11","author":[{"given":"J.","family":"Labenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Beker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.M.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Farley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.\u2010U.","family":"Kl\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,14]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"LamSK ChingCK LaiKC et al.Does treatment ofHelicobacter pylori(Hp) with antibiotics alone heal duodenal ulcer (DU)? Gastroenterology1996;11: A169 (Abstract)."},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","unstructured":"TytgatGNJ. Review article: treatments that impact favourably upon the eradication ofHelicobacter pyloriand ulcer recurrence. Aliment Pharmacol Ther1994;11:359\u201368.","DOI":"10.1111\/j.1365-2036.1994.tb00303.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","unstructured":"GrahamDY HeppsKS RamirezFC et al.Treatment ofHelicobacter pylorireduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol1993;11:939\u201342.","DOI":"10.3109\/00365529309098288"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","unstructured":"LabenzJ&B\u00f6rschGRole ofHelicobacter pylorieradication in the prevention of peptic ulcer bleeding relapse. Digestion1994;11:19\u201323.","DOI":"10.1159\/000201117"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","unstructured":"RokkasT KaramerisA MavrogeorgisA et al. Eradication ofHelicobacter pylorireduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc1995;11:1\u20134.","DOI":"10.1016\/S0016-5107(95)70266-0"},{"key":"e_1_2_1_7_2","unstructured":"HuangJQ SridharS WilkinsonJ et al.Antibiotics accelerate healing of duodenal ulcer (DU) when combined with proton pump inhibitors (PPI) or H2\u2010receptor antagonists (H2\u2010RA). Gastroenterology1996;11: A137 (Abstract)."},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","unstructured":"WilhelmsenI&BerstadA. Quality of life and relapse of duodenal ulcer before and after eradication ofHelicobacter pylori. Scand J Gastroenterol1994;11:874\u20139.","DOI":"10.3109\/00365529409094856"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","unstructured":"SonnenbergA&TownsendWFCosts of duodenal ulcer therapy with antibiotics. Arch Intern Med1995;11:922\u20138.","DOI":"10.1001\/archinte.155.9.922"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference.Helicobacter pyloriin peptic ulcer disease. J Am Med Assoc1994;11:65\u20139.","DOI":"10.1001\/jama.272.1.65"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","unstructured":"SollAHConsensus Statement. Medical treatment of peptic ulcer disease. Practical guidelines. J Am Med Assoc1996;11:622\u20139.","DOI":"10.1001\/jama.1996.03530320046033"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","unstructured":"UngeP GadA GnarpeH OlssonJDoes omeprazole improve antimicrobial therapy directed towards gastricCampylobacter pyloriin patients with antral gastritis? Scand J Gastroenterol1989;11(Suppl. 167):49\u201354.","DOI":"10.3109\/00365528909091311"},{"key":"e_1_2_1_13_2","unstructured":"LabenzJ&O'MorainCEradication. Curr Opin Gastroenterol1995;11(Suppl. 1):47\u201351."},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","unstructured":"PriceABThe Sydney system. Histological division. J Gastroenterol Hepatol1991;11:209\u201322.","DOI":"10.1111\/j.1440-1746.1991.tb01468.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","unstructured":"ErikssonSAAre ulcer healing and prophylaxis studies appropriately analysed? Eur J Gastroenterol Hepatol1995;11:1195\u20138.","DOI":"10.1097\/00042737-199512000-00012"},{"key":"e_1_2_1_16_2","unstructured":"UngeP GadA ErikssonK et al.Amoxycillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol1993;11:325\u201331."},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","unstructured":"KoelzHR BeglingerC InauenW et al.Double\u2010blind comparison of three different amoxycillin (amo) plus omeprazole (ome) regimens for eradication ofHelicobacter pylori(Hp) in patients with peptic ulcers. Gastroenterology1995;11: A133 (Abstract).","DOI":"10.1016\/0016-5085(95)23194-3"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","unstructured":"Bayerd\u00f6rfferE MiehlkeS MannesGA et al.Double\u2010blind trial of omeprazole and amoxicillin to cureHelicobacter pyloriinfection in patients with duodenal ulcers. Gastroenterology1996;11:1412\u20137.","DOI":"10.1016\/0016-5085(95)90689-4"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","unstructured":"PommerienW SchultzeV BradenB et al.Dose\u2013response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication ofHelicobacter pylori. Aliment Pharmacol Ther1996;11:303\u20138.","DOI":"10.1111\/j.0953-0673.1996.00303.x"},{"key":"e_1_2_1_20_2","unstructured":"MannesGA Bayerd\u00f6rfferE HeleC et al.An increasing dose of omeprazole combined with amoxicillin increases the eradication rate ofHelicobacter pylori.Gastroenterology1993;11: A140 (Abstract)."},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","unstructured":"BarnertJ DemharterR FleischmannR et al.Omeprazole plus amoxycillin inHelicobacter pyloriinfection: role of gastric pH\u2010metry in predicting successful eradication. Gastroenterology1995;11: A54 (Abstract).","DOI":"10.1016\/0016-5085(95)22879-9"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","unstructured":"LabenzJ StolteM BlumAL et al.Intragastric acidity as a predictor of the success ofHelicobacter pylorieradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut1995;11:39\u201343.","DOI":"10.1136\/gut.37.1.39"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","unstructured":"AndersenJ Str\u00f6mM NaesdalJ et al.Intravenous omeprazole: effect of a loading dose on 24\u2010h intragastric pH. Aliment Pharmacol Ther1990;11:65\u201372.","DOI":"10.1111\/j.1365-2036.1990.tb00450.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","unstructured":"LondongW LondongV CederbergC et al.Dose\u2013response study of omeprazole on meal\u2010stimulated gastric acid secretion and gastrin release. Gastroenterology1983;11:1373\u20138.","DOI":"10.1016\/S0016-5085(83)80020-1"},{"key":"e_1_2_1_25_2","unstructured":"TreiberGThe influence of drug dosage onHelicobacter pylorieradication: a cost\u2010effectiveness analysis. Am J Gastroenterol1996;11:246\u201357."},{"key":"e_1_2_1_26_2","unstructured":"CaroliA KusstatscherS BoniM et al.Eradication ofHelicobacter pylori:is a double therapy still suitable? Gut1995;11(Suppl. 1): A85 (Abstract)."},{"key":"e_1_2_1_27_2","unstructured":"CaylaR ZerbibF M\u00e9graudF et al.Clarithromycin resistance ofHelicobacter pyloristrains before and after treatment: a key factor of treatment failures. Gastroenterology1995;11: A63 (Abstract)."},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","unstructured":"MidoloPD LambertJR TurnidgeJMetronidazole resistance: a predictor of failure ofHelicobacter pylorieradication by triple therapy. J Gastroenterol Hepatol1996;11:290\u20132.","DOI":"10.1111\/j.1440-1746.1996.tb00078.x"},{"key":"e_1_2_1_29_2","unstructured":"GohKL PehSC ParasakthiN et al.Omeprazole 40\u2003mg with amoxycillin alone or with amoxycillin and metronidazole in the eradication ofHelicobacter pylori. Am J Gastroenterol1994;11:1789\u201392."},{"key":"e_1_2_1_30_2","unstructured":"RokkasT MavrogeorgisA LiatsosC et al.Optimal dose of omeprazole in combination with amoxicillin in eradicatingH. pyloriand preventing relapses in duodenal ulcer patients. Hepatogastroenterol1995;11:842\u20136."},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","unstructured":"SungJJY ChungSCS LingTKW et al.Dual therapy vs. triple therapy forHelicobacter pylori\u2010associated duodenal ulcers. Dig Dis Sci1996;11:453\u20137.","DOI":"10.1007\/BF02282317"},{"key":"e_1_2_1_32_2","unstructured":"ThijsJC Van ZwetAA MoolenaarW et al.Triple therapy vs. amoxicillin plus omeprazole for treatment ofHelicobacter pyloriinfection: a multicenter prospective randomized controlled study of efficacy and side effects. Am J Gastroenterol1996;11:93\u20137."},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","unstructured":"AthertonJC HudsonN KirkGE et al.Amoxycillin capsules with omeprazole for the eradication ofHelicobacter pylori. Assessment of the importance of antibiotic timing in relation to meals. Aliment Pharmacol Ther1994;11:495\u20138.","DOI":"10.1111\/j.1365-2036.1994.tb00321.x"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","unstructured":"LabenzJ LeverkusF B\u00f6rschGOmeprazole plus amoxicillin for cure ofHelicobacter pyloriinfection. Factors influencing the treatment success. Scand J Gastroenterol1994;11:1070\u20135.","DOI":"10.3109\/00365529409094890"},{"key":"e_1_2_1_35_2","unstructured":"ZalaG FluryR W\u00fcstJ et al.Omeprazol\/Amoxicillin: verbesserte Eradikation von Helicobacter pylori bei Rauchern durch N\u2010Acetylcystein. Schweiz Med Wochenschr1994;11:1391\u20137."},{"key":"e_1_2_1_36_2","unstructured":"GoddardA&LoganROne\u2010week low\u2010dose triple therapy: new standards forHelicobacter pyloritreatment. Eur J Gastroenterol Hepatol1995;11:1\u20133."},{"key":"e_1_2_1_37_2","unstructured":"LindT Veldhuyzen van ZantenSJO UngeP et al.The MACH 1 study: optimal one\u2010week treatment forH. pyloridefined? Gut1995;11(Suppl. 1): A4 (Abstract)."}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00169.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00169.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:55:45Z","timestamp":1698414945000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00169.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00169.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00169.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]}}}